Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection

Adipokines in liver diseases

(2009) Fabio Marra et al.   HEPATOLOGY

Treatment of chronic hepatitis C in Asia: When East meets West

(2009) Ming-Lung Yu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Chemerin, vaspin and insulin resistance in chronic hepatitis C

(2009) M. Kukla et al.   JOURNAL OF VIRAL HEPATITIS

Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine

(2008) Grit Sommer et al.   CLINICAL SCIENCE

Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease

(2008) R. Aller et al.   DIGESTIVE DISEASES AND SCIENCES

Hepatitis C virus infection: Molecular pathways to metabolic syndrome

(2008) Muhammad Y. Sheikh et al.   HEPATOLOGY

The novel adipocytokine visfatin exerts direct cardioprotective effects

(2008) Shiang Y. Lim et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C

(2008) Jee-Fu Huang et al.   JOURNAL OF HEPATOLOGY